77 results on '"Yonan N"'
Search Results
2. National Healthcare Delivery Systems Influence Lung Transplant Outcomes for Cystic Fibrosis
3. Cyclosporine Profiling With C 2 and C 0 Monitoring Improves Outcomes After Heart Transplantation
4. Angiotensin converting enzyme insertion/deletion polymorphism does not influence postcardiac transplantation hypertension onset or progression
5. The Effects of ACE Inhibition on Serum Angiotensin II Concentration Following Cardiac Transplantation
6. CD4−veCD8−ve CD30+ve T Cells Are Detectable in Human Lung Transplant Patients and Their Proportion of the Lymphocyte Population After In Vitro Stimulation With Donor Spleen Cells Correlates With Preservation of Lung Physiology
7. Donor CCR5 Δ32 Polymorphism and Outcome Following Cardiac Transplantation
8. The influence of donor age on transplant coronary artery disease and survival post heart transplantation: Is it safe to extend donor age?
9. Influence of tumor necrosis factor-α gene-308 polymorphism on the development of coronary vasculopathy after cardiac transplantation
10. Transforming growth factor-beta: association with arteriosclerosis and left ventricular dysfunction after heart transplantation
11. Does CMV Status Affect Morbidity and Survival Following Heart Transplantation? A Large Multicentre Retrospective Study
12. Polymorphism of the transforming growth factor–beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation
13. Does CMV Status Impact on Morbidity and Survival Following Heart Transplantation? A Large Multi-Centre Retrospective UK Study
14. Donor Heart Selection: Wythenshawe Experience
15. An investigation of the correlation between c-reactive protein, serum amyloid a concentration, and cardiac allograft rejection
16. (1032) - Predictors of Survival in Patients Undergoing VA-ECMO and the Utility of the SAVE Score in a UK Transplant Population
17. (678) - C-Reactive Protein (CRP) Correlates Poorly with Infection in the Post-Surgical Period Following Left Ventricular Assist Device (LVAD) Implantation
18. (564) - Outcomes and Characteristics of Patients with Critical Cardiogenic Shock Admitted to a Quaternary Heart Failure Unit in the UK
19. (566) - Predictors of Survival in Critical Cardiogenic Shock Admissions to a Quaternary Heart Failure Unit in the UK
20. (483) - Early CMV Management Post Lung Transplant(LTx): A 6-Year Review of Pre-Emptive Strategy for CMV
21. (876) - Outcome of CentriMag Extracorporeal Mechanical Circulatory Support Use in Critical Cardiogenic Shock (INTERMACS 1) Patients
22. (195) - A Study of Donor Ex-Vivo Lung Perfusion in UK Lung Transplantation (DEVELOP-UK)
23. (216) - Profiling Biomarkers of Inflammation and Tissue Injury during Human Ex Vivo Lung Perfusion in the DEVELOP-UK Study
24. (774) - Ultrastructural Changes in Epithelial and Endothelial Barriers During Ex-Vivo Lung Perfusion
25. (614) - CentriMag Short Term Ventricular Assist Device as a Bridge to Decision in Critical Cardiogenic Shock (INTERMACS 1) - The Manchester Experience
26. (676) - Thoratec CentriMag® for Temporary Treatment of Refractory Cardiogenic Shock or Severe Cardiopulmonary Insufficiency in Adult and Pediatric Patients: A Systematic Literature Review and Meta-Analysis of Observational Studies
27. (244) - The Effect of Cold and Warm Ischemia Time on Survival After Lung Transplantation in a Large National Cohort
28. Lung Transplantation from Donation after Cardiac Death – 3 Years Single Centre Experience
29. Prevalence of Psychological Distress and Stress Moderators in UK Transplant Candidates
30. Donation after Circulatory Death Lung Activity in the UK – 100 Transplants and Counting
31. 682 Outcome of Extracorporeal Membrane Oxygenation as Short Term Mechanical Support Following Heart Transplantation: A Single Centre Experience
32. 91 Equivalent Long Term Survival of Heart Transplant Patients Receiving Resuscitated Donor Hearts
33. 245 Wound Healing Events and Effusions with Everolimus Versus MMF Based Regimens in De Novo Heart Transplant Recipients
34. 526: The Depletion of Resident/Non-Classical Monocytes Is Associated with a Rise in Circulating Dendritic Cells in Lung Transplant Recipients with Bronchiolitis Obliterans Syndrome
35. 419: The Immunomodulation of Circulating CD4+ CD25 bright Regulatory T Cells by Pravastatin in a Heart Transplant Cohort
36. 422: Natural Killer Cells Deplete from Peripheral Blood and Increase in Myocardial Tissue during Acute Rejection Following Heart Transplantation
37. 552: Natural killer lymphocytes migrate to the lung during bronchiolitis obliterans syndrome
38. 447: The role of interleukin-7 in acute rejection following heart transplantation
39. 375: Increased serum concentrations of Th1 chemokines are associated with acute rejection following heart transplantation
40. 116: Lung malignancy incidence following lung transplantation
41. 72: Mannose-binding lectin – influence on acute graft rejection following heart transplantation
42. 73: Serum interleukin-12 concentration is associated with circulating basophils following heart transplantation
43. 65: The role of interleukin-15 in cytomegalovirus activation following heart transplantation
44. 67: Comparison of twenty eight key circulating immunologic messengers in heart transplant recipients treated with azathioprine vs Mycophenolate mofetil
45. 48: Association of CMV activation with Th1 chemokines in human heart transplant recipients
46. 50: Cell free soluble interleukin-2 receptor is associated with clinical stability following heart transplantation
47. 322: P-glycoprotein expression on peripheral blood mononuclear cells and biopsy proven acute rejection in heart transplantation
48. 250: C3435T polymorphism of the MDR1 gene and outcome in lung transplantation
49. Self-administered fingerprick sampling to determine cyclosporine C 2 blood levels in transplant patients
50. Cyclosprine profiling in heart transplant patients: Correlation with clinical outcome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.